PMID: 376021Apr 1, 1979Paper

Reconstruction of full-thickness loss skin wounds using skin collagen allografts

British Journal of Plastic Surgery
R F Oliver, R A Grant

Abstract

Sheets of allogeneic dermal collagen measuring 20 X 15 mm and prepared by trypsin treatment of full-thickness skin were grafted under skin flaps in rats. After 2 to 5 weeks the protective recipient skin was excised and replaced by split-thickness skin isografts which remained viable on their supportive collagen beds. On average such composite grafts maintained 84 per cent of their original size over 3 to 28 weeks and in contrast with split-thickness skin grafts achieved full-thickness reconstruction of the excised skin.

References

Jan 1, 1977·British Journal of Plastic Surgery·R F OliverA Mudie
Apr 1, 1974·British Journal of Plastic Surgery·I PrpicP Zamick
Nov 1, 1973·The Anatomical Record·J M ZikaL Klein
Apr 1, 1974·British Journal of Plastic Surgery·J C McGregor, G B Lindop

❮ Previous
Next ❯

Citations

Oct 1, 1982·British Journal of Plastic Surgery·R W Griffiths, P G Shakespeare
Jan 1, 1982·Biomaterials·R F OliverR A Grant
May 1, 1996·Burns : Journal of the International Society for Burn Injuries·Y TakamiR J Walter
Nov 19, 2003·Advanced Drug Delivery Reviews·Zbigniew Ruszczak
Jun 13, 1998·Burns : Journal of the International Society for Burn Injuries·R J WalterM Hanumadass
Feb 16, 2010·The Journal of Trauma·Nele BrusselaersStan Monstrey
Jul 21, 2009·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Sanjay RastogiBrijesh Sathian
Oct 1, 1987·Burns, Including Thermal Injury·R F Oliver
Jan 1, 1981·Connective Tissue Research·R F OliverR A Grant
Jan 26, 2017·Plastic and Reconstructive Surgery·Brent R DeGeorgeChristopher A Campbell
Nov 3, 1980·Biochimica Et Biophysica Acta·H BarkerL Stephen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.